Livzon Pharmaceutical Group Inc. Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc.

000513

Peringkat dalam Saham #4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
Harga Saham
$3.90
Kapitalisasi Pasar
$3.17B
Perubahan (1 hari)
-3.49%
Perubahan (1 tahun)
-25.88%
Negara
CN
Perdagangan Livzon Pharmaceutical Group Inc. (000513)

Kategori

Healthcare
Riwayat dividen untuk Livzon Pharmaceutical Group Inc. (000513)
Saham Livzon Pharmaceutical Group Inc. (simbol: 000513) telah membayar total 27 dividen.
Total semua dividen (disesuaikan dengan stock split): $13.88
Imbal hasil dividen (TTM): 0.0942
Pembayaran dividen untuk Livzon Pharmaceutical Group Inc. (000513) dari 1995 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
2026 (TTM) $1.02 -7.27%
2025 $1.10 -18.52%
2024 $1.35 -15.63%
2023 $1.60 23.08%
2022 $1.30 4.00%
2021 $1.25 8.69%
2020 $1.15 24.59%
2019 $0.9231 -22.00%
2018 $1.18 419.95%
2017 $0.2276 0.00%
2016 $0.2276 550.29%
2015 $0.035 -80.01%
2014 $0.1751 0.00%
2013 $0.1751 0.00%
2012 $0.1751 400.29%
2011 $0.035 -33.33%
2010 $0.0525 50.00%
2009 $0.035 -80.01%
2008 $0.1751 267.09%
2005 $0.0477 50.00%
2004 $0.0318 0.00%
2003 $0.0318 234.74%
2002 $0.0095 -40.25%
1999 $0.0159 -68.95%
1996 $0.0512 -33.33%
1995 $0.0768 0.00%
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
2026 (TTM) $1.02 -7.27%
2025 $1.10 -18.52%
2024 $1.35 -15.63%
2023 $1.60 23.08%
2022 $1.30 4.00%
2021 $1.25 8.69%
2020 $1.15 24.59%
2019 $0.9231 -53.85%
2018 $2.00 300.00%
2017 $0.5 0.00%
2016 $0.5 400.00%
2015 $0.1 -80.00%
2014 $0.5 0.00%
2013 $0.5 0.00%
2012 $0.5 400.00%
2011 $0.1 -33.33%
2010 $0.15 50.00%
2009 $0.1 -80.00%
2008 $0.5 233.33%
2005 $0.15 50.00%
2004 $0.1 0.00%
2003 $0.1 233.33%
2002 $0.03 -40.00%
1999 $0.05 -75.00%
1996 $0.2 -33.33%
1995 $0.3 0.00%
Pembayaran dividen untuk perusahaan sejenis atau pesaing